EDGAR Filing Documents for 0001144204-14-026909

Form 8-K - Current report:

SEC Accession No. 0001144204-14-026909

Filing Date

2014-05-01

Accepted

2014-05-01 17:19:37

Documents

Period of Report

2014-04-25

Items

Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v376221_8k.htm	8-K	21304
2	EXHIBIT 7.1	v376221_ex7-1.htm	EX-7.1	2940
	Complete submission text file	0001144204-14-026909.txt		25520

Mailing Address PEMBROKE HOUSE, 28-32 PEMBROKE ST UPPER DUBLIN L2 0000

Business Address PEMBROKE HOUSE, 28-32 PEMBROKE ST UPPER DUBLIN L2 0000 353971536401

Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)